330 related articles for article (PubMed ID: 24867988)
1. Carbapenem-resistant Klebsiella pneumoniae strains exhibit diversity in aminoglycoside-modifying enzymes, which exert differing effects on plazomicin and other agents.
Almaghrabi R; Clancy CJ; Doi Y; Hao B; Chen L; Shields RK; Press EG; Iovine NM; Townsend BM; Wagener MM; Kreiswirth B; Nguyen MH
Antimicrob Agents Chemother; 2014 Aug; 58(8):4443-51. PubMed ID: 24867988
[TBL] [Abstract][Full Text] [Related]
2. Association between the Presence of Aminoglycoside-Modifying Enzymes and In Vitro Activity of Gentamicin, Tobramycin, Amikacin, and Plazomicin against Klebsiella pneumoniae Carbapenemase- and Extended-Spectrum-β-Lactamase-Producing Enterobacter Species.
Haidar G; Alkroud A; Cheng S; Churilla TM; Churilla BM; Shields RK; Doi Y; Clancy CJ; Nguyen MH
Antimicrob Agents Chemother; 2016 Sep; 60(9):5208-14. PubMed ID: 27297487
[TBL] [Abstract][Full Text] [Related]
3. In Vitro Activity of Plazomicin Against Carbapenem Resistant Klebsiella pneumoniae Strains.
Demirbas Z; Ozger HS; Suzuk-Yildiz S; Bakkaloglu Z; Dizbay M
Clin Lab; 2022 Jun; 68(6):. PubMed ID: 35704736
[TBL] [Abstract][Full Text] [Related]
4. Nationwide epidemiology of carbapenem resistant Klebsiella pneumoniae isolates from Greek hospitals, with regards to plazomicin and aminoglycoside resistance.
Galani I; Nafplioti K; Adamou P; Karaiskos I; Giamarellou H; Souli M;
BMC Infect Dis; 2019 Feb; 19(1):167. PubMed ID: 30770727
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of plazomicin against β-lactamase-producing carbapenem-resistant Enterobacteriaceae (CRE).
Zhang Y; Kashikar A; Bush K
J Antimicrob Chemother; 2017 Oct; 72(10):2792-2795. PubMed ID: 29091224
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of the next-generation aminoglycoside plazomicin alone and in combination with colistin, meropenem, fosfomycin or tigecycline against carbapenemase-producing Enterobacteriaceae strains.
Rodríguez-Avial I; Pena I; Picazo JJ; Rodríguez-Avial C; Culebras E
Int J Antimicrob Agents; 2015 Dec; 46(6):616-21. PubMed ID: 26391381
[TBL] [Abstract][Full Text] [Related]
7. Comparative in vitro activity of plazomicin and older aminoglyosides against Enterobacterales isolates; prevalence of aminoglycoside modifying enzymes and 16S rRNA methyltransferases.
Gür D; Hasdemir U; Çakar A; Çavuşoğlu İ; Çelik T; Aksu B;
Diagn Microbiol Infect Dis; 2020 Aug; 97(4):115092. PubMed ID: 32569921
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of Aminoglycoside-Modifying Enzymes in Escherichia coli and Klebsiella pneumoniae Producing Extended Spectrum β-Lactamases Collected in Two Multicenter Studies in Spain.
Fernández-Martínez M; Ruiz Del Castillo B; Lecea-Cuello MJ; Rodríguez-Baño J; Pascual Á; Martínez-Martínez L;
Microb Drug Resist; 2018 May; 24(4):367-376. PubMed ID: 29727265
[TBL] [Abstract][Full Text] [Related]
9.
Castanheira M; Davis AP; Mendes RE; Serio AW; Krause KM; Flamm RK
Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29866862
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial activity of plazomicin against Enterobacteriaceae-producing carbapenemases from 50 Brazilian medical centers.
Martins AF; Bail L; Ito CAS; da Silva Nogueira K; Dalmolin TV; Martins AS; Rocha JLL; Serio AW; Tuon FF
Diagn Microbiol Infect Dis; 2018 Mar; 90(3):228-232. PubMed ID: 29223516
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of plazomicin compared to other clinically relevant aminoglycosides in carbapenem-resistant Enterobacteriaceae.
Clark JA; Kulengowski B; Burgess DS
Diagn Microbiol Infect Dis; 2020 Oct; 98(2):115117. PubMed ID: 32755805
[TBL] [Abstract][Full Text] [Related]
12. Emergence of the Novel Aminoglycoside Acetyltransferase Variant
Sato T; Wada T; Nishijima S; Fukushima Y; Nakajima C; Suzuki Y; Takahashi S; Yokota SI
mBio; 2020 Dec; 11(6):. PubMed ID: 33443109
[TBL] [Abstract][Full Text] [Related]
13. Comparison of in vitro activities of plazomicin and other aminoglycosides against clinical isolates of Klebsiella pneumoniae and Escherichia coli.
İnce G; Mirza HC; Üsküdar Güçlü A; Gümüş H; Erol Ç; Başustaoğlu A
J Antimicrob Chemother; 2021 Nov; 76(12):3192-3196. PubMed ID: 34499728
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of Plazomicin against Enterobacteriaceae isolates carrying genes encoding aminoglycoside-modifying enzymes most common in US Census divisions.
Castanheira M; Davis AP; Serio AW; Krause KM; Mendes RE
Diagn Microbiol Infect Dis; 2019 May; 94(1):73-77. PubMed ID: 30661726
[TBL] [Abstract][Full Text] [Related]
15.
Fleischmann WA; Greenwood-Quaintance KE; Patel R
Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31712206
[TBL] [Abstract][Full Text] [Related]
16. Aminoglycoside-resistance gene signatures are predictive of aminoglycoside MICs for carbapenem-resistant Klebsiella pneumoniae.
Huang Y; Rana AP; Wenzler E; Ozer EA; Krapp F; Bulitta JB; Hauser AR; Bulman ZP
J Antimicrob Chemother; 2022 Feb; 77(2):356-363. PubMed ID: 34668007
[TBL] [Abstract][Full Text] [Related]
17. KPC-producing Klebsiella pneumoniae strains that harbor AAC(6')-Ib exhibit intermediate resistance to amikacin.
Bremmer DN; Clancy CJ; Press EG; Almaghrabi R; Chen L; Doi Y; Nguyen MH; Shields RK
Antimicrob Agents Chemother; 2014 Dec; 58(12):7597-600. PubMed ID: 25288089
[TBL] [Abstract][Full Text] [Related]
18. Optimizing aminoglycoside selection for KPC-producing Klebsiella pneumoniae with the aminoglycoside-modifying enzyme (AME) gene aac(6')-Ib.
Butler DA; Rana AP; Krapp F; Patel SR; Huang Y; Ozer EA; Hauser AR; Bulman ZP
J Antimicrob Chemother; 2021 Feb; 76(3):671-679. PubMed ID: 33326561
[TBL] [Abstract][Full Text] [Related]
19. Colistin-sparing regimens against Klebsiella pneumoniae carbapenemase-producing K. pneumoniae isolates: Combination of tigecycline or doxycycline and gentamicin or amikacin.
Tang HJ; Lai CC; Chen CC; Zhang CC; Weng TC; Chiu YH; Toh HS; Chiang SR; Yu WL; Ko WC; Chuang YC
J Microbiol Immunol Infect; 2019 Apr; 52(2):273-281. PubMed ID: 27133391
[TBL] [Abstract][Full Text] [Related]
20. Structural and phylogenetic analyses of resistance to next-generation aminoglycosides conferred by AAC(2') enzymes.
Bassenden AV; Dumalo L; Park J; Blanchet J; Maiti K; Arya DP; Berghuis AM
Sci Rep; 2021 Jun; 11(1):11614. PubMed ID: 34078922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
